235 related articles for article (PubMed ID: 20027300)
1. Loss-of-function mutations in Rab escort protein 1 (REP-1) affect intracellular transport in fibroblasts and monocytes of choroideremia patients.
Strunnikova NV; Barb J; Sergeev YV; Thiagarajasubramanian A; Silvin C; Munson PJ; Macdonald IM
PLoS One; 2009 Dec; 4(12):e8402. PubMed ID: 20027300
[TBL] [Abstract][Full Text] [Related]
2. The functional effect of pathogenic mutations in Rab escort protein 1.
Sergeev YV; Smaoui N; Sui R; Stiles D; Gordiyenko N; Strunnikova N; Macdonald IM
Mutat Res; 2009 Jun; 665(1-2):44-50. PubMed ID: 19427510
[TBL] [Abstract][Full Text] [Related]
3. Single choroideremia gene in nonmammalian vertebrates explains early embryonic lethality of the zebrafish model of choroideremia.
Moosajee M; Tulloch M; Baron RA; Gregory-Evans CY; Pereira-Leal JB; Seabra MC
Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):3009-16. PubMed ID: 19117920
[TBL] [Abstract][Full Text] [Related]
4. Molecular genetics characterization and homology modeling of the CHM gene mutation: A study on its association with choroideremia.
Imani S; Ijaz I; Shasaltaneh MD; Fu S; Cheng J; Fu J
Mutat Res Rev Mutat Res; 2018; 775():39-50. PubMed ID: 29555028
[TBL] [Abstract][Full Text] [Related]
5. CHM/REP1 cDNA delivery by lentiviral vectors provides functional expression of the transgene in the retinal pigment epithelium of choroideremia mice.
Tolmachova T; Tolmachov OE; Wavre-Shapton ST; Tracey-White D; Futter CE; Seabra MC
J Gene Med; 2012 Mar; 14(3):158-68. PubMed ID: 22228595
[TBL] [Abstract][Full Text] [Related]
6. Silencing of the CHM gene alters phagocytic and secretory pathways in the retinal pigment epithelium.
Gordiyenko NV; Fariss RN; Zhi C; MacDonald IM
Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):1143-50. PubMed ID: 19741243
[TBL] [Abstract][Full Text] [Related]
7. Reduced Retinal Pigment Epithelial Autophagy Due to Loss of Rab12 Prenylation in a Human iPSC-RPE Model of Choroideremia.
Raeker MÖ; Perera ND; Karoukis AJ; Chen L; Feathers KL; Ali RR; Thompson DA; Fahim AT
Cells; 2024 Jun; 13(12):. PubMed ID: 38920696
[TBL] [Abstract][Full Text] [Related]
8. Gene Augmentation of CHM Using Non-Viral Episomal Vectors in Models of Choroideremia.
Toualbi L; Toms M; Almeida PV; Harbottle R; Moosajee M
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894906
[TBL] [Abstract][Full Text] [Related]
9. Visual impairment and REP-1 gene mutations in Japanese choroideremia patients.
Hayakawa M; Fujiki K; Hotta Y; Ito R; Ohki J; Ono J; Saito A; Nakayasu K; Kanai A; Ishidoh K; Kominami E; Yoshida K; Kim KC; Ohashi H
Ophthalmic Genet; 1999 Jun; 20(2):107-15. PubMed ID: 10420196
[TBL] [Abstract][Full Text] [Related]
10. A novel SVA retrotransposon insertion in the
Jones KD; Radziwon A; Birch DG; MacDonald IM
Ophthalmic Genet; 2020 Aug; 41(4):341-344. PubMed ID: 32441177
[TBL] [Abstract][Full Text] [Related]
11. Choroideremia: molecular mechanisms and therapies.
Sarkar H; Moosajee M
Trends Mol Med; 2022 May; 28(5):378-387. PubMed ID: 35341685
[TBL] [Abstract][Full Text] [Related]
12. Pathogenicity of a novel missense variant associated with choroideremia and its impact on gene replacement therapy.
Torriano S; Erkilic N; Faugère V; Damodar K; Hamel CP; Roux AF; Kalatzis V
Hum Mol Genet; 2017 Sep; 26(18):3573-3584. PubMed ID: 28911202
[TBL] [Abstract][Full Text] [Related]
13. Clinical and genetic studies in a family with a new splice-site mutation in the choroideremia gene.
Contestabile MT; Piane M; Cascone NC; Pasquale N; Ciarnella A; Recupero SM; Chessa L
Mol Vis; 2014; 20():325-33. PubMed ID: 24672218
[TBL] [Abstract][Full Text] [Related]
14. Expression of Rab Prenylation Pathway Genes and Relation to Disease Progression in Choroideremia.
Fry LE; Patrício MI; Jolly JK; Xue K; MacLaren RE
Transl Vis Sci Technol; 2021 Jul; 10(8):12. PubMed ID: 34254989
[TBL] [Abstract][Full Text] [Related]
15. Novel CHM mutations in Polish patients with choroideremia - an orphan disease with close perspective of treatment.
Skorczyk-Werner A; Wawrocka A; Kochalska N; Krawczynski MR
Orphanet J Rare Dis; 2018 Dec; 13(1):221. PubMed ID: 30541579
[TBL] [Abstract][Full Text] [Related]
16. Choroideremia: a review of general findings and pathogenesis.
Coussa RG; Traboulsi EI
Ophthalmic Genet; 2012 Jun; 33(2):57-65. PubMed ID: 22017263
[TBL] [Abstract][Full Text] [Related]
17. A practical diagnostic test for choroideremia.
MacDonald IM; Mah DY; Ho YK; Lewis RA; Seabra MC
Ophthalmology; 1998 Sep; 105(9):1637-40. PubMed ID: 9754170
[TBL] [Abstract][Full Text] [Related]
18. Whole-exome sequencing reveals a novel CHM gene mutation in a family with choroideremia initially diagnosed as retinitis pigmentosa.
Guo H; Li J; Gao F; Li J; Wu X; Liu Q
BMC Ophthalmol; 2015 Jul; 15():85. PubMed ID: 26216097
[TBL] [Abstract][Full Text] [Related]
19. REP1 deficiency causes systemic dysfunction of lipid metabolism and oxidative stress in choroideremia.
Cunha DL; Richardson R; Tracey-White D; Abbouda A; Mitsios A; Horneffer-van der Sluis V; Takis P; Owen N; Skinner J; Welch AA; Moosajee M
JCI Insight; 2021 May; 6(9):. PubMed ID: 33755601
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive mutation analysis (20 families) of the choroideremia gene reveals a missense variant that prevents the binding of REP1 with Rab geranylgeranyl transferase.
Esposito G; De Falco F; Tinto N; Testa F; Vitagliano L; Tandurella IC; Iannone L; Rossi S; Rinaldi E; Simonelli F; Zagari A; Salvatore F
Hum Mutat; 2011 Dec; 32(12):1460-9. PubMed ID: 21905166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
